AAAAAA

   
Results: 1-14 |
Results: 14
Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease
Authors: Piketty, C Jayle, D Leplege, A Castiel, P Ecosse, E Gonzalez-Canali, G Sabatier, B Boulle, N Debuire, B Le Bouc, Y Baulieu, EE Kazatchkine, MD
Citation: C. Piketty et al., Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease, CLIN ENDOCR, 55(3), 2001, pp. 325-330
Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
Authors: Landau, A Batisse, D Piketty, C Van Huyen, LPD Bloch, F Belec, L Bruneval, P Weiss, L Jian, R Kazatchkine, MD
Citation: A. Landau et al., Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients, AIDS, 15(16), 2001, pp. 2149-2155
Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen
Authors: Piketty, C Weiss, L Thomas, F Mohamed, AS Belec, L Kazatchkine, MD
Citation: C. Piketty et al., Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen, J INFEC DIS, 183(9), 2001, pp. 1328-1335
Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis
Authors: Piketty, C Bardin, C Gilquin, J Gairard, A Kazatchkine, MD Chast, F
Citation: C. Piketty et al., Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis, CL MICRO IN, 6(3), 2000, pp. 117-120
The 39th ICCAC (San Francisco, September 1999) - HIV infection in clinicalpractice
Authors: Piketty, C
Citation: C. Piketty, The 39th ICCAC (San Francisco, September 1999) - HIV infection in clinicalpractice, PRESSE MED, 29(3), 2000, pp. 153-154
Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients
Authors: Landau, A Batisse, D Van Huyen, JPD Piketty, C Bloch, F Pialoux, G Belec, L Petite, JP Weiss, L Kazatchkine, M
Citation: A. Landau et al., Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients, AIDS, 14(7), 2000, pp. 839-844
Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628
Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy
Authors: Landau, A Batisse, D Piketty, C Jian, R Kazatchkine, MD
Citation: A. Landau et al., Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy, AIDS, 14(12), 2000, pp. 1857-1858
Effect of interferon and ribavirin on HIV viral load
Authors: Landau, A Batisse, D Piketty, C Kazatchkine, MD
Citation: A. Landau et al., Effect of interferon and ribavirin on HIV viral load, AIDS, 14(1), 2000, pp. 96-97
The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients
Authors: Karmochkine, M Mohamed, AS Piketty, C Ginsburg, C Raguin, G Schneider-Fauveau, V Gutmann, L Kazatchkine, MD Belec, L
Citation: M. Karmochkine et al., The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients, ANTIVIR RES, 47(3), 2000, pp. 179-188
High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure ofprotease inhibitor-containing antiretroviral combination therapy
Authors: Belec, L Piketty, C Si-Mohamed, A Goujon, C Hallouin, MC Cotigny, S Weiss, L Kazatchkine, MD
Citation: L. Belec et al., High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure ofprotease inhibitor-containing antiretroviral combination therapy, J INFEC DIS, 181(5), 2000, pp. 1808-1812
Aggregates market in France
Authors: Arquie, G Camus, A Charreau, M Dubus, JL Dupont, P Piketty, C
Citation: G. Arquie et al., Aggregates market in France, AGGREGATES, 2000, pp. 1-23
Lack of legal income is strongly associated with an increased risk of AIDSand death in HIV-infected injecting drug users
Authors: Piketty, C Castiel, P Giral, P Lhomme, JP Boubilley, D Olievenstein, C Lert, F Kazatchkine, MD
Citation: C. Piketty et al., Lack of legal income is strongly associated with an increased risk of AIDSand death in HIV-infected injecting drug users, AIDS CARE, 11(4), 1999, pp. 429-436
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy
Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy, AIDS, 13(11), 1999, pp. F71-F77
Risultati: 1-14 |